Skip Ribbon Commands
Skip to main content

Dr. Bashar Al-Khalidi

:

Published Research: Bioequivalence assessment of clarithromycin extended release 500 mg tablets under fasting and fed conditions: An open-label, single-dose, randomized, two-way, two-period cross-over study in healthy Jordanian male volunteers

Research Title

 Bioequivalence assessment of clarithromycin extended release 500 mg tablets under fasting and fed conditions: An open-label, single-dose, randomized, two-way, two-period cross-over study in healthy Jordanian male volunteers

Authors
• B. Alkhalidi, J.Tamimi, I.Salem, , H.Ibrahim and A. Sallam.

Journal
Clinical Therapeutics

Volume & Page Numbers

 vol. 30, No.10, 2008

Publisher
Elsevier Science /USA 

Year

 2009

Attachments

bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions.pdf    
Content Type: Announcement
Created at 3/4/2010 3:37 PM by Bashar Al-Khalidi
Last modified at 8/19/2011 6:55 PM by System Account